Draxis, Eli Lilly Canada Inc. sales and marketing update

DRAXF renewed its exclusive license for Canadian marketing of Lilly's Permax pergolide mesylate to treat Parkinson's disease. Lilly will manufacture Permax and supply it to DRAXF for an additional 10...